BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 12376499)

  • 21. Risk of recurrent spontaneous abortion, cigarette smoking, and genetic polymorphisms in NAT2 and GSTM1.
    Mendola P; Moysich KB; Freudenheim JL; Shields PG; Schisterman EF; Graham S; Vena JE; Marshall JR; Ambrosone CB
    Epidemiology; 1998 Nov; 9(6):666-8. PubMed ID: 9799179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary mutagenicity, CYP1A2 and NAT2 activity in textile industry workers.
    Fanlo A; Sinuès B; Mayayo E; Bernal L; Soriano A; Martínez-Jarreta B; Martínez-Ballarín E
    J Occup Health; 2004 Nov; 46(6):440-7. PubMed ID: 15613766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow.
    Sinués B; Sáenz MA; Lanuza J; Bernal ML; Fanlo A; Juste JL; Mayayo E
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):159-66. PubMed ID: 10067814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot study of free and conjugated urinary mutagenicity during consumption of pan-fried meats: possible modulation by cruciferous vegetables, glutathione S-transferase-M1, and N-acetyltransferase-2.
    DeMarini DM; Hastings SB; Brooks LR; Eischen BT; Bell DA; Watson MA; Felton JS; Sandler R; Kohlmeier L
    Mutat Res; 1997 Nov; 381(1):83-96. PubMed ID: 9403034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
    Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
    Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of glutathione S-transferase polymorphisms on genotoxic effects induced by tobacco smoke.
    Palma S; Cornetta T; Padua L; Cozzi R; Appolloni M; Ievoli E; Testa A
    Mutat Res; 2007 Sep; 633(1):1-12. PubMed ID: 17644396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets.
    Lampe JW; King IB; Li S; Grate MT; Barale KV; Chen C; Feng Z; Potter JD
    Carcinogenesis; 2000 Jun; 21(6):1157-62. PubMed ID: 10837004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-acetyltransferase-2 activities.
    McQuilkin SH; Nierenberg DW; Bresnick E
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):139-46. PubMed ID: 7742721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excretion of mutagens, nicotine and its metabolites in urine of cigarette smokers.
    Granella M; Priante E; Nardini B; Bono R; Clonfero E
    Mutagenesis; 1996 Mar; 11(2):207-11. PubMed ID: 8671740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH.
    Lodovici M; Luceri C; Guglielmi F; Bacci C; Akpan V; Fonnesu ML; Boddi V; Dolara P
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1342-8. PubMed ID: 15298956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carotenoids/vitamin C and smoking-related bladder cancer.
    Castelao JE; Yuan JM; Gago-Dominguez M; Skipper PL; Tannenbaum SR; Chan KK; Watson MA; Bell DA; Coetzee GA; Ross RK; Yu MC
    Int J Cancer; 2004 Jun; 110(3):417-23. PubMed ID: 15095308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers.
    Hirvonen A; Nylund L; Kociba P; Husgafvel-Pursiainen K; Vainio H
    Carcinogenesis; 1994 May; 15(5):813-5. PubMed ID: 8200080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study.
    Manfredi S; Federici C; Picano E; Botto N; Rizza A; Andreassi MG
    Mutat Res; 2007 Aug; 621(1-2):106-12. PubMed ID: 17408703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary mutagenicity and colorectal adenoma risk.
    Peters U; DeMarini DM; Sinha R; Brooks LR; Warren SH; Chatterjee N; Rothman N
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1253-6. PubMed ID: 14652290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioactivation of the heterocyclic aromatic amine 2-amino-3-methyl-9H-pyrido [2,3-b]indole (MeAalphaC) in recombinant test systems expressing human xenobiotic-metabolizing enzymes.
    Glatt H; Pabel U; Meinl W; Frederiksen H; Frandsen H; Muckel E
    Carcinogenesis; 2004 May; 25(5):801-7. PubMed ID: 14729582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of metabolic genotypes on biomarkers of exposure to 1,3-butadiene in humans.
    Fustinoni S; Soleo L; Warholm M; Begemann P; Rannug A; Neumann HG; Swenberg JA; Vimercati L; Colombi A
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1082-90. PubMed ID: 12376511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GSTM1 and NAT2 genotypes and urinary mutagens in coke oven workers.
    Gabbani G; Hou SM; Nardini B; Marchioro M; Lambert B; Clonfero E
    Carcinogenesis; 1996 Aug; 17(8):1677-81. PubMed ID: 8761425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thioether excretion, urinary mutagenicity, and metabolic phenotype in smokers.
    Sinués B; Rueda P; Benítez J; Saenz MA; Bernal ML; Lanuza J; Alda O; Tres A; Bartolome M
    J Toxicol Environ Health; 1994 Nov; 43(3):327-38. PubMed ID: 7966441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-oxidative metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in humans: excretion of the N2-glucuronide conjugate of 2-hydroxyamino-MeIQx in urine.
    Stillwell WG; Turesky RJ; Sinha R; Tannenbaum SR
    Cancer Res; 1999 Oct; 59(20):5154-9. PubMed ID: 10537291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene.
    Nakajima M; Yokoi T; Mizutani M; Shin S; Kadlubar FF; Kamataki T
    Cancer Epidemiol Biomarkers Prev; 1994; 3(5):413-21. PubMed ID: 7920209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.